VRK2 rs1518395: Weight Regulation and Exercise Response
The rs1518395 single nucleotide polymorphism is an intronic variant located in the VRK2 gene on human chromosome 2. Preliminary exercise genomics research links this marker to body mass regulation and variable weight loss following structured endurance exercise programs. However, because broader genome-wide association studies predominantly connect this locus to neurological pathways, overall evidence regarding its metabolic and training effects remains limited.
What each genotype means
Baseline genetic profile
This genotype represents the absence of the G allele associated with increased risk for certain psychiatric conditions in large-scale studies. Research indicates that the G allele, rather than the A allele, is linked to higher statistical risk for schizophrenia and major depressive disorder. This association is based on population-level data and does not predict individual health outcomes.
This is the more common genotype in many populations, though exact frequencies vary significantly by ancestry.
Intermediate risk association
Carrying one copy of the G allele has been associated with a modest increase in the statistical risk for schizophrenia and major depressive disorder in large genome-wide association studies. These findings reflect population-wide trends and are not diagnostic of any condition. Please consult with a healthcare professional if you have concerns about your mental health or family history.
This heterozygous genotype is found in a significant portion of the population, with prevalence varying by ancestral background.
Increased risk association
This genotype is associated with a higher statistical likelihood of schizophrenia and major depressive disorder compared to those without the G allele, according to large-scale genetic research. These associations are based on population averages and do not mean that an individual will develop these conditions. Discuss any health concerns or family history with a qualified clinician.
This genotype is less common than the AA or AG combinations in many European populations, though it remains a notable genetic variant in the general population.
Genomic Location and Variant Characteristics
The single nucleotide polymorphism rs1518395 represents a common base substitution located in intron 1 of the VRK2 gene on the short arm of chromosome 2 (2p16.1). As an intronic variant, it does not alter the amino acid sequence of the encoded protein directly. Instead, research cataloged in genomic databases indicates that it sits in a noncoding regulatory context, potentially acting through linkage disequilibrium with other nearby regulatory variants or modifying local chromatin dynamics. Linkage disequilibrium analyses reveal that rs1518395 is co-inherited with several adjacent variants across a broad genomic span in populations of European ancestry, whereas in East Asian populations, the linked region is considerably narrower. In human populations, the major allele is adenine (A), while the minor alternative allele is guanine (G). Because it resides in a noncoding region, its biological effects in human tissues are mediated through subtle modulations of cellular signaling or gene regulation rather than structural protein disruption.
The Biological Function of the VRK2 Gene
The VRK2 gene encodes vaccinia-related kinase 2, a member of the vaccinia-related kinase family of serine/threonine protein kinases. Unlike soluble cytosolic kinases, VRK2 is largely anchored to the membranes of the endoplasmic reticulum and mitochondria. Biochemically, VRK2 plays an active role in cellular stress responses, cell cycle progression, apoptosis, and signal transduction cascades, including the MAPK/ERK and JNK signaling pathways. Functional genomics profiling, including multi-tissue transcriptomic studies of exercise adaptations such as the Molecular Transducers of Physical Activity Consortium (MoTrPAC), indicates that VRK2 expression is modulated across metabolic and neuromuscular tissues under physiological stress. By phosphorylating key downstream transcription factors and regulatory partners, the kinase influences how cells adapt to metabolic shifts, hypoxia, and inflammatory cues. Understanding VRK2 function helps explain why genetic variations in this locus could theoretically influence systemic adaptation to prolonged physical exertion.
Current Scientific Evidence: Weight Loss and Training Response
In exercise genetics and fitness trait studies, rs1518395 has been evaluated for its association with body mass regulation and individual variation in body weight reduction following endurance training protocols. While preliminary intervention studies suggest that carriers of specific alleles experience differential rates of body mass change during structured aerobic programs, the overall strength of this association is classified as limited. In contrast, large-scale genome-wide association studies (GWAS) have repeatedly mapped rs1518395 and closely linked variants to neurodevelopmental and psychiatric traits, such as schizophrenia and major depressive disorder, with rigorous statistical significance. Large cohorts, including the Psychiatric Genomics Consortium, demonstrated that the G allele at rs1518395 exhibits modest odds ratios for these traits across European and East Asian cohorts. Therefore, while candidate studies link rs1518395 to exercise-induced weight changes, large-scale independent replication in diverse metabolic cohorts is still required before definitive conclusions can be drawn.
Population Distribution and Ancestral Patterns
The alleles of rs1518395 are common across global human populations, though precise frequencies fluctuate across ancestries. According to large-scale population reference databases such as the Genome Aggregation Database (gnomAD) and the Human Genome Diversity Project (HGDP), the minor G allele occurs at an estimated frequency of approximately 35% (0.35) in individuals of European descent. In East Asian populations, including Han Chinese cohorts, the G allele appears at comparable frequencies, often between 30% and 40%, whereas distinct allele distributions and linkage architectures are observed in African and Admixed American populations. Linkage disequilibrium structures around rs1518395 also differ between ancestral groups, meaning that any putative functional variant tagged by rs1518395 in one population might not correlate with the exact same genetic signals in another ancestry group.
Practical Implications and Limitations
Discovering your rs1518395 genotype should be viewed as an educational glimpse into polygenic variation rather than a predictive blueprint for fitness success or body weight. Body composition, resting energy expenditure, and individual responsiveness to cardiovascular training are complex, multifactorial traits governed by hundreds of common genetic variants alongside diet, sleep quality, training intensity, and baseline metabolic health. A single intronic marker in VRK2 cannot determine whether you will lose weight on an endurance regimen, nor does it guarantee specific physical adaptations. Genetic information from commercial panels should never replace balanced lifestyle habits, evidence-based training principles, or clinical guidance. If you are starting an intense physical activity regimen or aiming to address clinical weight management, consulting a physician, registered dietitian, or certified exercise specialist provides far greater personal and medical value than adjusting workouts to individual genotype results.
How common is this variant?
The minor G allele has an estimated frequency of approximately 0.35 (35%) in European populations according to gnomAD reference data, with comparable frequencies observed in East Asian cohorts and varying linkage disequilibrium architectures across global populations.
Frequently asked questions
Does the rs1518395 variant dictate my success with cardio workouts?
No, your genotype at rs1518395 does not determine whether cardio workouts will be effective for you. Physical conditioning and changes in body composition are polygenic traits driven by hundreds of genes along with training intensity, consistency, and nutritional balance.
What is the function of the VRK2 gene?
VRK2 produces vaccinia-related kinase 2, an enzyme anchored to intracellular membranes that helps regulate cellular stress, signaling pathways, and cell survival. Researchers study VRK2 to understand how tissues respond to various forms of cellular, metabolic, and environmental stress.
Why is the evidence linking rs1518395 to weight loss rated as limited?
The connection between rs1518395 and endurance weight loss is based on small candidate intervention trials that have not yet achieved consistent, large-scale replication. In broader genomics databases, the variant is primarily noted for statistical associations with neurological and psychiatric phenotypes rather than primary metabolic traits.
Can testing rs1518395 help me choose the best exercise program?
Genetic test results for rs1518395 alone are not medically actionable and cannot reliably design an optimal fitness plan. General guidelines recommending regular cardiovascular exercise, progressive resistance training, and appropriate nutrition remain the most effective approach for fitness and weight management.
Sources & further reading
Educational information only, last refreshed 9/7/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs1518395?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29